TY  - GEN
AU  - Locatelli,Franco
AU  - Mauz-Koerholz,Christine
AU  - Neville,Kathleen
AU  - Llort,Anna
AU  - Beishuizen,Auke
AU  - Daw,Stephen
AU  - Pillon,Marta
AU  - Aladjidi,Nathalie
AU  - Klingebiel,Thomas
AU  - Landman-Parker,Judith
AU  - Medina-Sanson,Aurora
AU  - August,Keith
AU  - Sachs,Jessica
AU  - Hoffman,Kristen
AU  - Kinley,Judith
AU  - Song,Sam
AU  - Song,Gregory
AU  - Zhang,Stephen
AU  - Suri,Ajit
AU  - Gore,Lia
TI  - Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
SN  - 2352-3026
PY  - 2018///1122
KW  - Adolescent
KW  - Brentuximab Vedotin
KW  - Child
KW  - Child, Preschool
KW  - Female
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunoconjugates
KW  - therapeutic use
KW  - Lymphoma, Large-Cell, Anaplastic
KW  - Male
KW  - Recurrence
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1016/S2352-3026(18)30153-4
ER  -